Ending AIDS: HIV,ART,and PrEP in the Context of New Global Political Realities

Laurence J . “AIDS at a crossroads:” Highlights from the 2024 UNAIDS Report. AIDS Patient Care STDS, 2024; 38(11):493–494.

UNAIDS. The Urgency of now: AIDS at a Crossroads—2024 Global AIDS Update. Available from: https://www.unaids.org/en/resources/documents/2024/global-aids-update-2024

Beyrer C . Not done yet. The HIV pandemic in 2025. In: 32nd annual Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, March 9-12, 2025. 2025.

Velloza J , Poovan N , Meisner A , et al. Adaptive HIV pre-exposure prophylaxis adherence interventions for young women in Johannesburg, South Africa: A sequential multiple-assignment randomized trial. Lancet HIV, 2025; 12(2):e105–e117.

Ponce J , Okano JT , Low A , et al. Extreme geographic misalignment of healthcare resources and HIV treatment deserts in Malawi. Nature Med, 2025; doi: 10.1038/s41591-025-03561-6

Senn S , Roberson ND , Brunet L , et al. Rejection of federal guidance by southern US states and projected consequences for ending the HIV epidemic. AIDS Patient Care STDs, 2024; 38:559–565.

Tram KH , Ratevosian J , Beyrer C . By executive order: The likely deadly consequences associated with a 90-day pause in PEPFAR funding. J Intl AIDS Society, 2025; 28:e26431.

Mandavilli A . White House Ponders Shutting Down Agency’s H.I.V. Prevention Division. NY Times; 2025.

Beyrer C , Tomaras GD , Gelderblom HC , et al. Is HIV epidemic control by 2030 realistic? Lancet HIV, 2024; 11(7):e489–e494.

Editorial. The demise of UNAIDS: Time to rethink foreign aid? Lancet, 2025; 405:951.

Stockman F. Farewell to foreign aid as we know it. NY Times; 2025.

Ryom L . The potential for annual long-acting HIV pre-exposure prophylaxis. Lancet, 2025; 405(10485):1120–1121; doi: 10.1016/S0140-6736(25)00452-0

Gray GE , Venter WDF . Working at Cross-PURPOSEs to Ending HIV. N Engl J Med, 2025; 392(13):1344–1345; doi: 10.1056/NEJMe2414709